Cognition Therapeutics has announced topline results from its Phase 2 Magnify study, evaluating the ...
read more
At the 2025 ARVO Annual Meeting in Salt Lake City, a multi-stakeholder coalition announced the offic...
read more
Isarna Therapeutics presented the final results from its Phase 2 BETTER trial on May 6 at the Associ...
read more
EyeCool Therapeutics has announced encouraging results from a double-masked, randomized controlled p...
read more
Perfuse Therapeutics has announced promising 24-week results from its Phase 1/2a clinical trial eval...
read more
LumiThera has announced promising results from its LIGHTSITE 3B extension trial, highlighting contin...
read more
Topcon Healthcare has officially launched the Institute of Digital Health (IDHea), a next-generation...
read more
Alkeus Pharmaceuticals, Inc. presented additional 24-month results from its Phase 2 SAGA clinical tr...
read more
Aldeyra Therapeutics has announced that its investigational dry eye disease (DED) candidate, reproxa...
read more
Innovent Biologics has announced the latest 1-year results from its Phase 2 clinical trial evaluatin...
read more
More
